CyteGen
Wauwatosa
About CyteGen
CyteGen discovers new pathways that impact mitochondrial fitness and demonstrated recovery of cardiovascular and neurological function via therapeutic intervention.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.1M
- Last round: Series Unknown (Jan 2022)
- Website: cytegen.com
- Phone: 650-473-0701
Industries & Categories
Education, Health Care, Medical
Canonical: https://fsome.com/organization/cytegen-206274 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.